Skip to main content

Journal of Neuro-Oncology

Ausgabe 1/2024

Inhalt (23 Artikel)

Open Access Review

The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review

Jayne S. Wilson, Caroline Main, Nicky Thorp, Roger E. Taylor, Saimma Majothi, Pamela R. Kearns, Martin English, Madhumita Dandapani, Robert Phillips, Keith Wheatley, Barry Pizer

Open Access Correction

Correction to: The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review

Jayne S. Wilson, Caroline Main, Nicky Thorp, Roger E. Taylor, Saimma Majothi, Pamela R. Kearns, Martin English, Madhumita Dandapani, Robert Phillips, Keith Wheatley, Barry Pizer

Review

Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review

Eric Singh, Muhammet Enes Gurses, Meredith C. Costello, Chandler Berke, Victor M. Lu, Lekhaj Daggubati, Ricardo J. Komotar, Michael E. Ivan, Ashish H. Shah

Correction

Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review

Eric Singh, Muhammet Enes Gurses, Meredith C. Costello, Chandler Berke, Victor M. Lu, Lekhaj Daggubati, Ricardo J. Komotar, Michael E. Ivan, Ashish H. Shah

Open Access Research

Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery

Motoyuki Umekawa, Yuki Shinya, Hirotaka Hasegawa, Ramin A. Morshed, Atsuto Katano, Aya Shinozaki-Ushiku, Nobuhito Saito

Research

CPLX2 is a novel tumor suppressor and improves the prognosis in glioma

Yuanbing Chen, Jieling Ning, Long Shu, Lingzhi Wen, Bokang Yan, Zuli Wang, Junhong Hu, Xiaokun Zhou, Yongguang Tao, Xuewei Xia, Jun Huang

Open Access Research

The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma

Yukina Shirai, Toshihide Ueno, Shinya Kojima, Hiroshi Ikeuchi, Rina Kitada, Takafumi Koyama, Fumiyuki Takahashi, Kazuhisa Takahashi, Koichi Ichimura, Akihiko Yoshida, Hirokazu Sugino, Hiroyuki Mano, Yoshitaka Narita, Masamichi Takahashi, Shinji Kohsaka

Open Access Research

Validation of a methylation-based signature for subventricular zone involvement in glioblastoma

Felix Ehret, Oliver Zühlke, Leonille Schweizer, Johannes Kahn, Christoph Csapo-Schmidt, Siyer Roohani, Daniel Zips, David Capper, Sebastian Adeberg, Amir Abdollahi, Maximilian Knoll, David Kaul

Research

Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype

Antonio Dono, Jose Torres, Luis Nunez, Octavio Arevalo, Juan Carlos Rodriguez-Quinteros, Roy F. Riascos, Arash Kamali, Nitin Tandon, Leomar Y. Ballester, Yoshua Esquenazi

Open Access Research

Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes

Thais Baccili Cury Megid, Zeynep Baskurt, Lucy X. Ma, Carly C. Barron, Abdul Farooq, Marie Phillipe Saltiel, Xin Wang, Yvonne Bach, Hiroko Ayoama, Raymond W. Jang, Eric Chen, Patrick Veit-Haibach, Ben Wang, Sangeetha Kalimuthu, James Cotton, Rebecca Wong, Aruz Mesci, Elena Elimova

Open Access Research

Evaluating contouring accuracy and dosimetry impact of current MRI-guided adaptive radiation therapy for brain metastases: a retrospective study

Bin Wang, Yimei Liu, Jun Zhang, Shaohan Yin, Biaoshui Liu, Shouliang Ding, Bo Qiu, Xiaowu Deng

Open Access Research

Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas

Naureen Keric, Harald Krenzlin, Darius Kalasauskas, Christian F. Freyschlag, Oliver Schnell, Martin Misch, Christian von der Brelie, Jens Gempt, Aleksandrs Krigers, Arthur Wagner, Felipa Lange, Dorothee Mielke, Clemens Sommer, Marc A. Brockmann, Bernhard Meyer, Veit Rohde, Peter Vajkoczy, Jürgen Beck, Claudius Thomé, Florian Ringel

Research

The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study

Vincenzo Di Nunno, Giuseppe Lombardi, Matteo Simonelli, Giuseppe Minniti, Angela Mastronuzzi, Valentina Di Ruscio, Martina Corrà, Marta Padovan, Marta Maccari, Mario Caccese, Giorgia Simonetti, Arianna Berlendis, Mariangela Farinotti, Bianca Pollo, Manila Antonelli, Antonio Di Muzio, Angelo Dipasquale, Sofia Asioli, Dario De Biase, Alicia Tosoni, Antonio Silvani, Enrico Franceschi

Open Access Research

Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection

David Wasilewski, Julia Onken, Paul Höricke, Jan Bukatz, Selin Murad, Anton Früh, Zoe Shaked, Martin Misch, Anja Kühl, Oliver Klein, Felix Ehret, David Kaul, Helena Radbruch, David Capper, Peter Vajkoczy, David Horst, Nikolaj Frost, Philip Bischoff

Case Study

Effect of sarcopenia and frailty on outcomes among patients with brain metastases

Mervyn Jun Rui Lim, Zheting Zhang, Yilong Zheng, Ivan Wei Loon Khoo, Rhianne Caitlin Vaz Xin Ying, Sophie Jia Qian Koh, Ethanyn Lim, Pei Ing Ngam, Betsy Soon, Ying Liang Low, Li Feng Tan, Kejia Teo, Vincent Diong Weng Nga, Tseng Tsai Yeo

Case Study

The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab

Pushan Dasgupta, Alexander Ou, Heather Lin, Timothy Gregory, Kristin D. Alfaro-Munoz, Ying Yuan, Vahid Afshar-Khargan, Carlos Kamiya-Matsuoka, Justin F. Rousseau, Nazanin K. Majd

Case Study

CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization

Manali Ranade, Sridhar Epari, Omshree Shetty, Sandeep Dhanavade, Sheetal Chavan, Ayushi Sahay, Arpita Sahu, Prakash Shetty, Aliasgar Moiyadi, Vikash Singh, Archya Dasgupta, Abhishek Chatterjee, Sadhana Kannan, Tejpal Gupta

Correction

Correction to: CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization

Manali Ranade, Sridhar Epari, Omshree Shetty, Sandeep Dhanavade, Sheetal Chavan, Ayushi Sahay, Arpita Sahu, Prakash Shetty, Aliasgar Moiyadi, Vikash Singh, Archya Dasgupta, Abhishek Chatterjee, Sadhana Kannan, Tejpal Gupta

Open Access Case Study

Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review

Yasuhito Kegoya, Yoshihiro Otani, Yohei Inoue, Ryo Mizuta, Fumiyo Higaki, Kana Washio, Shinichiro Koizumi, Kazuhiko Kurozumi, Joji Ishida, Kentaro Fujii, Norio Yamamoto, Yoshihiro Tanaka, Isao Date

Case Study

Incidence and imaging characteristics of difficult to detect retrospectively identified brain metastases in patients receiving repeat courses of stereotactic radiosurgery

Andrew Fairchild, Joseph K. Salama, Devon Godfrey, Walter F. Wiggins, Bradley G. Ackerson, Taofik Oyekunle, Donna Niedzwiecki, Peter E. Fecci, John P. Kirkpatrick, Scott R. Floyd

Correspondence

Stereotactic radiosurgery for intracranial adenoid cystic carcinoma

Jason P. Sheehan, Raj Singh, Daniel M. Trifiletti

Correspondence

Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma

Jason P. Sheehan, Georgios Mantziaris, Adomas Bunevicius

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.